Weihai Baihe Biology Technological Co. Ltd.
Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutrit… Read more
Weihai Baihe Biology Technological Co. Ltd. (603102) - Net Assets
Latest net assets as of June 2025: CN¥1.67 Billion CNY
Based on the latest financial reports, Weihai Baihe Biology Technological Co. Ltd. (603102) has net assets worth CN¥1.67 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.87 Billion) and total liabilities (CN¥196.93 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.67 Billion |
| % of Total Assets | 89.48% |
| Annual Growth Rate | 28.23% |
| 5-Year Change | 176.85% |
| 10-Year Change | N/A |
| Growth Volatility | 34.56 |
Weihai Baihe Biology Technological Co. Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Weihai Baihe Biology Technological Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Weihai Baihe Biology Technological Co. Ltd. (2019–2024)
The table below shows the annual net assets of Weihai Baihe Biology Technological Co. Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.61 Billion | +6.04% |
| 2023-12-31 | CN¥1.51 Billion | +6.50% |
| 2022-12-31 | CN¥1.42 Billion | +99.25% |
| 2021-12-31 | CN¥713.72 Million | +23.04% |
| 2020-12-31 | CN¥580.08 Million | +25.31% |
| 2019-12-31 | CN¥462.92 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Weihai Baihe Biology Technological Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 166.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥810.42 Million | 50.46% |
| Other Components | CN¥795.51 Million | 49.54% |
| Total Equity | CN¥1.61 Billion | 100.00% |
Weihai Baihe Biology Technological Co. Ltd. Competitors by Market Cap
The table below lists competitors of Weihai Baihe Biology Technological Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SHE:002731
|
$148.12 Million |
|
Albatron Technology Co Ltd
TWO:5386
|
$148.21 Million |
|
VIVO Cannabis Inc
PINK:ABCCF
|
$148.26 Million |
|
ARTRYA Ltd
AU:AYA
|
$148.36 Million |
|
Hefei Changqing Machinery Co Ltd
SHG:603768
|
$148.11 Million |
|
GTL Infrastructure Limited
NSE:GTLINFRA
|
$148.08 Million |
|
Limes Schlosskliniken AG
XETRA:LIK
|
$148.07 Million |
|
Comintel Corporation Berhad
KLSE:7195
|
$148.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Weihai Baihe Biology Technological Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,514,464,172 to 1,605,932,194, a change of 91,468,022 (6.0%).
- Net income of 139,309,115 contributed positively to equity growth.
- Dividend payments of 47,234,700 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥139.31 Million | +8.67% |
| Dividends Paid | CN¥47.23 Million | -2.94% |
| Other Changes | CN¥-606.39K | -0.04% |
| Total Change | CN¥- | 6.04% |
Book Value vs Market Value Analysis
This analysis compares Weihai Baihe Biology Technological Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.71x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.44x to 1.71x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥9.64 | CN¥42.86 | x |
| 2020-12-31 | CN¥12.08 | CN¥42.86 | x |
| 2021-12-31 | CN¥14.87 | CN¥42.86 | x |
| 2022-12-31 | CN¥22.22 | CN¥42.86 | x |
| 2023-12-31 | CN¥23.66 | CN¥42.86 | x |
| 2024-12-31 | CN¥25.09 | CN¥42.86 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Weihai Baihe Biology Technological Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.67%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 17.38%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 1.13x
- Recent ROE (8.67%) is below the historical average (14.71%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 16.06% | 14.88% | 0.81x | 1.34x | CN¥28.04 Million |
| 2020 | 21.91% | 21.98% | 0.79x | 1.26x | CN¥69.11 Million |
| 2021 | 20.74% | 22.37% | 0.72x | 1.28x | CN¥76.67 Million |
| 2022 | 9.69% | 19.00% | 0.44x | 1.17x | CN¥-4.36 Million |
| 2023 | 11.16% | 19.40% | 0.50x | 1.15x | CN¥17.62 Million |
| 2024 | 8.67% | 17.38% | 0.44x | 1.13x | CN¥-21.28 Million |
Industry Comparison
This section compares Weihai Baihe Biology Technological Co. Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,496,572,190
- Average return on equity (ROE) among peers: -3.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Weihai Baihe Biology Technological Co. Ltd. (603102) | CN¥1.67 Billion | 16.06% | 0.12x | $148.11 Million |
| Xiwang Foodstuffs Co Ltd (000639) | $65.61 Million | -62.17% | 1.91x | $345.26 Million |
| Nanfang Black Sesame Group Co Ltd (000716) | $199.49 Million | -32.62% | 2.81x | $346.21 Million |
| CNFC Overseas Fishery Co Ltd (000798) | $727.64 Million | 8.49% | 0.27x | $430.25 Million |
| Henan Shuanghui Investment & Development Co Ltd (000895) | $16.36 Billion | 24.69% | 0.34x | $3.98 Billion |
| Xinjiang Chalkis Co Ltd (000972) | $760.28 Million | -33.42% | 2.17x | $202.97 Million |
| Zhengzhou Qianweiyangchu Food Co Ltd (001215) | $332.95 Million | 17.62% | 0.88x | $266.09 Million |
| Wenzhou Yuanfei Pet Toy Products Co. Ltd. A (001222) | $1.35 Billion | 9.31% | 0.15x | $160.97 Million |
| Guangdong Yuehai Feeds Group Co.Ltd. (001313) | $2.07 Billion | 7.87% | 0.47x | $169.20 Million |
| Shandong Oriental Ocean Sci-Tech Co Ltd (002086) | $393.72 Million | 8.08% | 0.70x | $460.31 Million |
| Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd (002100) | $2.70 Billion | 14.52% | 0.66x | $903.18 Million |